Compare CURV & LUCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CURV | LUCD |
|---|---|---|
| Founded | 2001 | 2018 |
| Country | United States | United States |
| Employees | 7590 | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 169.8M | 183.5M |
| IPO Year | 2021 | 2021 |
| Metric | CURV | LUCD |
|---|---|---|
| Price | $1.73 | $1.17 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 4 |
| Target Price | $1.59 | ★ $3.94 |
| AVG Volume (30 Days) | ★ 1.4M | 628.0K |
| Earning Date | 03-19-2026 | 03-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 36.36 | 16.67 |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $1,103,737,000.00 | $4,346,000.00 |
| Revenue This Year | N/A | $7.04 |
| Revenue Next Year | $0.21 | $152.30 |
| P/E Ratio | $172.00 | ★ N/A |
| Revenue Growth | N/A | ★ 79.00 |
| 52 Week Low | $0.94 | $0.95 |
| 52 Week High | $6.69 | $1.80 |
| Indicator | CURV | LUCD |
|---|---|---|
| Relative Strength Index (RSI) | 77.05 | 29.85 |
| Support Level | $1.63 | $1.01 |
| Resistance Level | $1.96 | $1.22 |
| Average True Range (ATR) | 0.15 | 0.06 |
| MACD | 0.05 | -0.03 |
| Stochastic Oscillator | 78.98 | 0.00 |
Torrid Holdings Inc is a direct-to-consumer brand of apparel, intimates, and accessories in North America. The company is focused on fit and offers high-quality products across a broad assortment that includes tops, bottoms, denim, dresses, intimates, activewear, footwear, and accessories. The company has one reportable segment, which includes the operation of the e-commerce platform and stores. The company generates revenue from the sale of apparel, intimates, and accessories through its e-commerce platform and its store locations.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.